Assessing the risk of UV-induced skin cancer via non-invasive epidermal sampling
Assessing the risk of UV-induced skin cancer via non-invasive epidermal sampling
批准号:
8810480
负责人:
Samir S Mitragotri
金额:
$23.15万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-02-01 至 2018-01-31
关键词:
AccountingAddressAgeBRAF geneBiological MarkersBiopsy SpecimenCancerousCarcinomaCategoriesChemistryClinicalCollectionCutaneousDNADNA DamageDNA Mutational AnalysisDNA Sequence AlterationDNA photoproductsDataDevelopmentDiseaseDoseEnsureEnvironmental Risk FactorEpidermisFrequenciesGoalsHarvestHematologic NeoplasmsHistologyHistopathologyHourHumanInbred HRS MiceIncidenceInduced MutationKineticsLesionLibrariesLinkLiquid substanceMalignant NeoplasmsMeasurementMeasuresMechanicsMediatingMedicalMethodologyMethodsModelingMolecular ProfilingMolecular WeightMorbidity - disease rateMosaicismMutationMutation DetectionPatientsPharmaceutical PreparationsProcessProductivityRecoveryResearchRiskRisk AssessmentSafetySamplingSkinSkin CancerSkin CarcinomaSourceStructureTP53 geneTechnologyTestingThymine DimersTimeTumor Suppressor GenesUV inducedUV induced DNA damageUltrasonicsUltrasonographyUltraviolet B RadiationUltraviolet Raysbasecancer riskcombinatorialcosteconomic impactexomegenome sequencinginhibitor/antagonistirradiationkeratinocytemelanomamortalitymouse modelnext generation sequencingnovelperipheral bloodpublic health relevancerapid techniqueskin squamous cell carcinomasurfactanttoolultraviolet irradiation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The objective of this study is to develop "a methodology for sampling DNA from skin to assess the risk of UV-induced skin cancer development". Our goal is to establish non-invasive biomarker sampling from skin for a variety of systemic and cutaneous diseases. Here, we will focus on measurement of UV-induced DNA mutations that are linked to all skin cancers, both non-melanoma skin cancers and melanoma alike. Our central hypothesis is that the non- invasive collection and mutational analysis of DNA from clinically-normal skin correlates with the level of risk for skin cancer. We will demonstrate this in a mouse model of UV-induced skin cancer using our novel methods. Our specific aims are: Specific Aim 1: Optimize ultrasound-assisted sampling of DNA from skin. We will first assess the optimal ultrasound (intensity, duty cycle and exposure time) and microdermabrasion (contact roughness and oscillation frequency) parameters to maximize the total amount of DNA extracted from the skin. We will also optimize the chemistry of the sampling medium (liquid used to couple mechanical energy to the skin) to maximize the amount and stability of collected DNA using a combinatorial library of surfactants chosen from four categories (cationic, anionic, zwitterionic and non-ionic surfactants). Our goal is to harvest at least 5 ug DNA per sq. cm of skin and ensure its stability (>80%) for 4 hours. Specific Aim 2: Evaluate the safety of the sampling process. We will perform detailed histopathology assessment of sampled skin to determine the effect of ultrasound on skin structure. Recovery kinetics of skin after sampling will
be assessed. Our target is recovery of skin within 7 days based on histology. Specific Aim 3: Validate the use of UV mutational load in skin as a biomarker of skin cancer risk. Using chronically UV-irradiated Hairless mice, we will characterize the burden of UV signature mutations in skin following ultrasonic DNA extraction at multiple time points following irradiation We will test whether DNA collected from chronically UV-exposed skin by ultrasound can be used to measure the UV-induced mutation burden in terms of DNA photoproducts (thymine dimers), UV signature lesions in particular susceptible genes (Tp53, Hras, Kras, Ink4a), and UV signature mutations across the entire exome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2017 Barrier Function of Mammalian Skin Gordon Research Conference
-
批准号:9405707
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2017
-
负责人:Samir S Mitragotri
-
依托单位:
Assessing the risk of UV-induced skin cancer via non-invasive epidermal sampling
-
批准号:9198526
-
项目类别:
-
资助金额:$18.95万
-
财政年份:2015
-
负责人:Samir S Mitragotri
-
依托单位:
Orally bioactive exenatie and insulin for type II diabetes
-
批准号:9087209
-
项目类别:
-
资助金额:$32.34万
-
财政年份:2013
-
负责人:Samir S Mitragotri
-
依托单位:
Orally bioactive exenatie and insulin for type II diabetes
-
批准号:8578665
-
项目类别:
-
资助金额:$30.31万
-
财政年份:2013
-
负责人:Samir S Mitragotri
-
依托单位:
Orally bioactive exenatie and insulin for type II diabetes
-
批准号:8695344
-
项目类别:
-
资助金额:$30.24万
-
财政年份:2013
-
负责人:Samir S Mitragotri
-
依托单位:
Cutaneous Gene Therapy with Ultrasound: DNA Vaccination
-
批准号:6859302
-
项目类别:
-
资助金额:$17.69万
-
财政年份:2005
-
负责人:Samir S Mitragotri
-
依托单位:
Cutaneous Gene Therapy with Ultrasound: DNA Vaccination
-
批准号:7006955
-
项目类别:
-
资助金额:$14.89万
-
财政年份:2005
-
负责人:Samir S Mitragotri
-
依托单位:
A Novel and Non-Invasive Method of Dermal Sampling
-
批准号:6436289
-
项目类别:
-
资助金额:$7.13万
-
财政年份:2002
-
负责人:Samir S Mitragotri
-
依托单位:
A Novel and Non-Invasive Method of Dermal Sampling
-
批准号:6752107
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2002
-
负责人:Samir S Mitragotri
-
依托单位:
海外基金